Jeff Goad, a myeloma patient diagnosed in 2010, is one of the MMRF’s most active participants. He climbed to Kilimanjaro with a team of 16, including 3 other patients in 2016, as part of the first Moving Mountains for Multiple Myeloma (MM4MM) teams. Last year he trekked in Nepal in-route to Everest Base Camp with another group that included his wife. He is often taking part in marathons with his two brothers, Brad and David (Boston, NYC, Chicago) Together, they are known as “The Brother’s Goad”. Jeff and Brad are riding together on the 2022 team this year.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More